SLC34A2 and breast cancer: We observed that high expression of SLC34A2 was positively associated with larger tumor size (P=0.017; P=0.012, respectively) and advanced T status (P<0.001; P=0.008, respectively) both in training and validation cohorts of BC cases (Table 1).